Estrogen receptor alpha signaling in dendritic cells modulates autoimmune disease phenotype in mice. (12th January 2023)

• Record Type: Journal Article
• Authors: Khaw, Yee Ming; Anwar, Shehata; Zhou, Jinyan; Kawano, Tasuku; Lin, Po‐Ching; Otero, Ashley; Barakat, Radwa; Drnevich, Jenny; Takahashi, Tomoko; Ko, CheMyong Jay; Inoue, Makoto
• Is Part Of: EMBO reports. Volume 24:Number 3(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2023-01-12
• Subjects: CNS neurodegenerative -- estrogen -- extragonadal organ -- membrane lymphotoxin -- phenotype change; Molecular biology -- Periodicals; Molecular Biology -- Periodicals; Molecular biology; Periodicals; 572.8
• DOI: 10.15252/embr.202154228
• Languages: English
• ISSNs: 1469-221X

Abstract

Abstract: Estrogen is a disease‐modifying factor in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) via estrogen receptor alpha (ERα). However, the mechanisms by which ERα signaling contributes to changes in disease pathogenesis have not been completely elucidated. Here, we demonstrate that ERα deletion in dendritic cells (DCs) of mice induces severe neurodegeneration in the central nervous system in a mouse EAE model and resistance to interferon beta (IFNβ), a first‐line MS treatment. Estrogen synthesized by extragonadal sources is crucial for controlling disease phenotypes. Mechanistically, activated ERα directly interacts with TRAF3, a TLR4 downstream signaling molecule, to degrade TRAF3 via ubiquitination, resulting in reduced IRF3 nuclear translocation and transcription of membrane lymphotoxin (mLT) and IFNβ components. Diminished ERα signaling in DCs generates neurotoxic effector CD4 + T cells via mLT‐lymphotoxin beta receptor (LTβR) signaling. Lymphotoxin beta receptor antagonist abolished EAE disease symptoms in the DC‐specific ERα‐deficient mice. These findings indicate that estrogen derived from extragonadal sources, such as lymph nodes, controls TRAF3‐mediated cytokine production in DCs to modulate the EAE disease phenotype. Synopsis: ERα signaling in dendritic cells (DCs) suppresses the activation of neurotoxic CD4 + T cells and thereby modulates mouse autoimmune disease phenotypes. This effect is mediated by endogenous estrogen derived from extragonadal sources. Estrogen derived from extragonadal sites modulates disease phenotype in a mouse model of experimental autoimmune encephalomyelitis (EAE) dependent on ERα function in DCs. DC‐specific ERα knockout mice express high levels of membrane lymphotoxin (mLT) and interferon beta (IFNβ) and show prolonged disease and severe neurodegeneration in the central nervous system. ERα interacts with TRAF3 downstream of TLR4 activation to suppress the synthesis of IFNβ and mLT. Increased expression of IFNβ and mLT in the absence of ERα renders resistance to exogenous IFNβ treatment and induces neurodegeneration, respectively. Abstract : ERα signaling in dendritic cells suppresses the activation of neurotoxic CD4 + T cells and thereby modulates mouse autoimmune disease phenotypes. This effect is mediated by endogenous estrogen derived from extragonadal sources.